about
Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjectsA Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingV3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV.Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis.Geno2pheno[454]: a Web server for the prediction of HIV-1 coreceptor usage from next-generation sequencing data.HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study.HIV-1 mutational pathways under multidrug therapy.High concordance between the position-specific scoring matrix and geno2pheno algorithms for genotypic interpretation of HIV-1 tropism: V3 length as the major cause of disagreementTherapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case reportDeep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patientsPrediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach.Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA.APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1.In-depth analysis of G-to-A hypermutation rate in HIV-1 env DNA induced by endogenous APOBEC3 proteins using massively parallel sequencing.Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
P50
Q28478134-69071375-CE85-46C9-A0CA-2D790831BA18Q28552356-BB43D40A-3E8E-41E7-988C-C2AE663E676BQ33509526-7CCEC5B9-26A6-4865-A44D-5C8DFFF7882BQ33899080-A36F203D-32EA-4642-B2B6-1C5765672A44Q34144135-0FE2DC4D-EE8A-4EE0-993E-28DDB43F53D5Q34923915-589EDE38-5DEA-4579-A9B7-F02E6C085A31Q36403427-A64FEB96-15BF-462E-9A6E-C5D2498A5980Q38264403-0DE6B383-36EC-414D-9B41-6050466B65B2Q38285227-E39D0903-0085-4A2C-AE97-074DE7A0C7CDQ38887171-10B42012-53AB-4222-A846-7D28302C79CBQ39118296-762349AC-B3E5-40C7-9AC8-F57BC1B17413Q41991922-B51123C6-3EC4-4659-9792-B33545FB58EBQ42186680-ACD1E7AF-853C-40CE-A913-0EAF20A81971Q42872799-ED245A87-2169-4B43-A391-250CCDB14629Q42926976-CE62F6C5-90D3-46BB-8422-E6481F81B904Q43050513-389CBD96-5DEE-441E-9B3E-3F9D19F5D231Q43591116-5AA23535-B64B-4054-85D2-13067B4BEB49Q44197028-6D2DA280-6D3B-42CC-B3AC-15205C6570BCQ44398468-AC78D3E9-2AEA-43B1-AF3E-BA05932B08DAQ45026495-6387FD9C-BA27-4E6C-B52A-A1A290C3B4AA
P50
name
Alexander Thielen
@ast
Alexander Thielen
@en
Alexander Thielen
@es
Alexander Thielen
@fr
Alexander Thielen
@nl
type
label
Alexander Thielen
@ast
Alexander Thielen
@en
Alexander Thielen
@es
Alexander Thielen
@fr
Alexander Thielen
@nl
prefLabel
Alexander Thielen
@ast
Alexander Thielen
@en
Alexander Thielen
@es
Alexander Thielen
@fr
Alexander Thielen
@nl